Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cognitive-behavioral group treatment for disabling headache.

Justin M Nash1, Elyse R Park, Barbara B Walker

  • 1Centers for Behavioral and Preventive Medicine, Brown Medical School and The Miriam Hospital, Lifespan Academic Medical Center, Providence, Rhode Island 02903, USA. Justin_Nash@Brown.edu

Pain Medicine (Malden, Mass.)
|June 24, 2004
PubMed
Summary

Cognitive-behavioral group treatment significantly improved headache frequency, intensity, and duration for individuals with disabling headaches. This approach reduced medication use and enhanced quality of life for many participants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Building a Community Partnership to Meet the Needs of Parents of Neurodivergent Children.

Progress in community health partnerships : research, education, and action·2026
Same author

Building a Community Partnership to Meet the Needs of Parents of Neurodivergent Children.

Progress in community health partnerships : research, education, and action·2026
Same author

A Resiliency Intervention to Support Nurses Engaged in the Provision of HIV Care in KwaZulu-Natal, South Africa: Protocol for a Pilot Randomized Controlled Trial.

JMIR research protocols·2026
Same author

E-cigarettes for tobacco harm reduction in older adults who fail tobacco cessation treatment offered at lung cancer screening: a pilot trial.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026
Same author

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors.

JAMA network open·2026

Area of Science:

  • Neurology
  • Behavioral Science
  • Health Services Research

Background:

  • Severe, disabling headaches impose significant costs on individuals and society.
  • Standard treatments, including prophylactic agents and triptans, are insufficient for many.
  • Psychological and behavioral factors play a crucial role in chronic headache management.

Purpose of the Study:

  • To investigate the efficacy of a cognitive-behavioral group treatment for chronic, disabling headaches.
  • To assess if this group format offers an intensive, cost-effective clinic-based intervention.
  • To evaluate improvements in headache symptoms, medication use, and quality of life.

Main Methods:

  • Development and piloting of a 10-session cognitive-behavioral group treatment program.

Related Experiment Videos

  • Study conducted at an academic medical center's behavioral headache management program.
  • Involved 62 individuals with moderate to severe primary headache disorder, assessed pre- and post-treatment.
  • Main Results:

    • Significant improvements observed in headache frequency, intensity, duration, and quality of life.
    • Reduced symptomatic medication use was noted post-treatment.
    • Fifty percent of participants achieved at least a 50% reduction in headache frequency.

    Conclusions:

    • Clinic-based, group-format cognitive-behavioral treatment shows preliminary effectiveness for disabling headaches.
    • The intervention successfully decreased headache activity and symptomatic medication reliance.
    • Improved quality of life was a key outcome for participants in the study.